The Biotech Growth Trust PLC - Confirmation of Portfolio Management Arrangements
News provided by
The Biotech Growth Trust PLC03 Aug, 2026, 07:30 GMT
3 August 2026
The Biotech Growth Trust PLC
(the "Company")
Confirmation of Portfolio Management Arrangements
The Board of the Company notes the announcement by Worldwide Healthcare Trust PLC regarding changes to its portfolio management arrangements and confirms that there is no change to the Company's portfolio management arrangements. Geoff Hsu remains lead portfolio manager of the Company, supported by Josh Golomb as co-portfolio manager.
Roger Yates, Chair, commented: "The Biotech Growth Trust will maintain its focus on providing shareholders with exposure to the exciting opportunities in the global biotech sector and the Board is confident that Geoff, Josh and the wider team at OrbiMed are well placed to deliver the Company's investment objective."
Katherine Manson
Frostrow Capital LLP, Company Secretary
Telephone: 020 3709 8734
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
